Current:Home > MarketsCharles H. Sloan-Pig transplant research yields a surprise: Bacon safe for some people allergic to red meat -GrowthInsight
Charles H. Sloan-Pig transplant research yields a surprise: Bacon safe for some people allergic to red meat
Charles H. Sloan View
Date:2025-04-06 10:19:42
BLACKSBURG,Charles H. Sloan Va. (AP) — Some people who develop a weird and terrifying allergy to red meat after a bite from a lone star tick can still eat pork from a surprising source: Genetically modified pigs created for organ transplant research.
Don’t look for it in grocery stores. The company that bred these special pigs shares its small supply, for free, with allergy patients.
“We get hundreds and hundreds of orders,” said David Ayares, who heads Revivicor Inc., as he opened a freezer jammed with packages of ground pork patties, ham, ribs and pork chops.
The allergy is called alpha-gal syndrome, named for a sugar that’s present in the tissues of nearly all mammals - except for people and some of our primate cousins. It can cause a serious reaction hours after eating beef, pork or any other red meat, or certain mammalian products such as milk or gelatin.
David Ayares, president and chief scientific officer of Revivicor, holds a package of frozen meat during an interview at the company’s offices in Blacksburg, Va., on May 30, 2024. (AP Photo/Shelby Lum)
But where does organ transplantation come in? There aren’t enough donated human organs to go around so researchers are trying to use organs from pigs instead — and that same alpha-gal sugar is a big barrier. It causes the human immune system to immediately destroy a transplanted organ from an ordinary pig. So the first gene that Revivicor inactivated as it began genetically modifying pigs for animal-to-human transplants was the one that produces alpha-gal.
While xenotransplants still are experimental, Revivicor’s “GalSafe” pigs won Food and Drug Administration approval in 2020 to be used as a source of food, and a potential source for human therapeutics. The FDA determined there was no detectable level of alpha-gal across multiple generations of the pigs.
Revivicor, a subsidiary of United Therapeutics, isn’t a food company — it researches xenotransplantation. Nor has it yet found anyone in the agriculture business interested in selling GalSafe pork.
Still, “this is a research pig that FDA approved so let’s get it to the patients,” is how Ayares describes beginning the shipments a few years ago.
Revivicor’s GalSafe herd is housed in Iowa and to keep its numbers in check, some meat is periodically processed in a slaughterhouse certified by the U.S. Agriculture Department. Revivicor then mails frozen shipments to alpha-gal syndrome patients who’ve filled out applications for the pork.
Thank-you letters relating the joy of eating bacon again line a bulletin board near the freezer in Revivicor’s corporate office.
Deeper reading
- Learn how one family’s choice to donate a body for pig kidney research could help change transplants.
- Research on pig-to-human organ transplants, or xenotransplantation, has yielded a surprising benefit for people with red meat allergies caused by the bite of a lone star tick.
- Read more about the latest in organ transplant research.
Separately, pigs with various gene modifications for xenotransplant research live on a Revivicor farm in Virginia, including a GalSafe pig that was the source for a recent experimental kidney transplant at NYU Langone Health.
And that begs the question: After removing transplantable organs, could the pig be used for meat?
No. The strong anesthesia used so the animals feel no pain during organ removal means they don’t meet USDA rules for drug-free food, said United Therapeutics spokesman Dewey Steadman.
—-
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.
veryGood! (989)
Related
- 2 killed, 3 injured in shooting at makeshift club in Houston
- Democrat Janelle Bynum flips Oregon’s 5th District, will be state’s first Black member of Congress
- 'America's flagship' SS United States has departure from Philadelphia to Florida delayed
- West Virginia expands education savings account program for military families
- Juan Soto to be introduced by Mets at Citi Field after striking record $765 million, 15
- Natural gas flares sparked 2 wildfires in North Dakota, state agency says
- 'Survivor' 47, Episode 9: Jeff Probst gave players another shocking twist. Who went home?
- Kim Kardashian and Kourtney Kardashian Team Up for SKIMS Collab With Dolce & Gabbana After Feud
- Buckingham Palace staff under investigation for 'bar brawl'
- Paraguay vs. Argentina live updates: Watch Messi play World Cup qualifying match tonight
Ranking
- DeepSeek: Did a little known Chinese startup cause a 'Sputnik moment' for AI?
- KFC sues Church's Chicken over 'original recipe' fried chicken branding
- Florida Man Arrested for Cold Case Double Murder Almost 50 Years Later
- Donna Kelce Includes Sweet Nod to Taylor Swift During Today Appearance With Craig Melvin
- The FBI should have done more to collect intelligence before the Capitol riot, watchdog finds
- FBI raids New York City apartment of Polymarket CEO Shayne Coplan, reports say
- What Republicans are saying about Matt Gaetz’s nomination for attorney general
- Off the Grid: Sally breaks down USA TODAY's daily crossword puzzle, Good Try (Freestyle)
Recommendation
Krispy Kreme offers a free dozen Grinch green doughnuts: When to get the deal
Jake Paul's only loss led him to retool the team preparing him to face Mike Tyson
Gold is suddenly not so glittery after Trump’s White House victory
Martin Scorsese on the saints, faith in filmmaking and what his next movie might be
As Trump Enters Office, a Ripe Oil and Gas Target Appears: An Alabama National Forest
2 striking teacher unions in Massachusetts face growing fines for refusing to return to classroom
Bodyless head washes ashore on a South Florida beach
College football Week 12 expert picks for every Top 25 game include SEC showdowns